BioNano Genomics To Present At Upcoming J.P. Morgan Healthcare Conference
Published: Jan 10, 2014
SAN DIEGO, Jan. 10, 2014 /PRNewswire/ -- BioNano Genomics announced today that Erik Holmlin, Ph.D., BioNano's president and CEO, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16th at 12:00 p.m. PST.
About BioNano Genomics
Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform, the Irys® System, provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.
Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.
SOURCE BioNano Genomics
Help employers find you! Check out all the jobs and post your resume.